Manesh R Patel

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Which beta-blocker for heart failure?
    Manesh R Patel
    Division of Cardiology and the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 147:238. 2004
  2. ncbi request reprint Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
    David B Matchar
    Duke Center for Clinical Health Policy Research, Duke Clinical Research Institute, Duke University, and Durham U S Department of Veterans Affairs Medical Center, Durham, North Carolina 27705, USA
    Ann Intern Med 148:16-29. 2008
  3. ncbi request reprint Clinical trial issues in weight-loss therapy
    Manesh R Patel
    Duke University Medical Center, Durham, NC 27708, USA
    Am Heart J 151:633-42. 2006
  4. doi request reprint End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 6:470-8. 2013
  5. doi request reprint Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial
    Rajendra H Mehta
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 163:797-803. 2012
  6. doi request reprint Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in at
    Graeme J Hankey
    From the School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia G J H Department of Neurology, Sir Charles Gairdner Hospital, Perth, Australia G J H Duke Clinical Research Institute S R S, J P P, Y L, M R P and Duke Translational Medicine Institute R M C, Duke University Medical Center, Durham, NC Department of Medicine, Stanford University, CA K W M Cardiovascular Institute, Mount Sinai Medical Center, New York J L H Department of Cardiovascular Medicine, Hospital of the University of Münster, Munster, Germany G B Massachusetts General Hospital and Harvard Medical School, Boston D E S University of Cincinnati College of Medicine, OH R C B Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, NJ S D B Cerenis Therapeutics, Labege, France J F P Janssen Research and Development, Raritan, NJ C C N Ruprecht Karls University, Heidelberg, Germany W H and University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom K A A F
    Stroke 45:1304-12. 2014
  7. doi request reprint Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Ann Intern Med 158:861-8. 2013
  8. doi request reprint Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K ant
    Jonathan P Piccini
    Division of Cardiology, Duke University Medical Center, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27710, USA
    Circulation 127:224-32. 2013
  9. pmc Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stro
    Matthew W Sherwood
    Division of Cardiovascular Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC M W S, M R P, J P P, A S H, Y L, R M C, R C B Department of Medicine, Division of Hematology and Thromboembolism, McMaster University, Hamilton, Ontario, Canada J D D Department of Medicine, Division of Hematology, Hofstra North Shore LIJ School of Medicine, Lenox Hill Hospital, New York, NY A C S School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia G J H Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA D E S Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ C C N Department of Medicine, Stanford University Medical Center, Palo Alto, CA K W M and Department of Medicine, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom K A A F
    Circulation 129:1850-9. 2014
  10. doi request reprint High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 165:809-15, 815.e1. 2013

Collaborators

Detail Information

Publications120 found, 100 shown here

  1. ncbi request reprint Which beta-blocker for heart failure?
    Manesh R Patel
    Division of Cardiology and the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 147:238. 2004
  2. ncbi request reprint Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
    David B Matchar
    Duke Center for Clinical Health Policy Research, Duke Clinical Research Institute, Duke University, and Durham U S Department of Veterans Affairs Medical Center, Durham, North Carolina 27705, USA
    Ann Intern Med 148:16-29. 2008
    ..The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown...
  3. ncbi request reprint Clinical trial issues in weight-loss therapy
    Manesh R Patel
    Duke University Medical Center, Durham, NC 27708, USA
    Am Heart J 151:633-42. 2006
    ..Effective obesity therapies also have the potential for off-label use and unintended consequences...
  4. doi request reprint End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 6:470-8. 2013
    ..To evaluate the previously reported excess of thromboembolic events during the 30 days after the end of study (EOS) visit when participants transitioned from blinded therapy to open-label vitamin K antagonist...
  5. doi request reprint Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial
    Rajendra H Mehta
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 163:797-803. 2012
    ..Information on practice patterns and outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventions (PCIs) in Canada vs United States is limited...
  6. doi request reprint Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in at
    Graeme J Hankey
    From the School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia G J H Department of Neurology, Sir Charles Gairdner Hospital, Perth, Australia G J H Duke Clinical Research Institute S R S, J P P, Y L, M R P and Duke Translational Medicine Institute R M C, Duke University Medical Center, Durham, NC Department of Medicine, Stanford University, CA K W M Cardiovascular Institute, Mount Sinai Medical Center, New York J L H Department of Cardiovascular Medicine, Hospital of the University of Münster, Munster, Germany G B Massachusetts General Hospital and Harvard Medical School, Boston D E S University of Cincinnati College of Medicine, OH R C B Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, NJ S D B Cerenis Therapeutics, Labege, France J F P Janssen Research and Development, Raritan, NJ C C N Ruprecht Karls University, Heidelberg, Germany W H and University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom K A A F
    Stroke 45:1304-12. 2014
    ..Intracranial hemorrhage (ICH) is a life-threatening complication of anticoagulation...
  7. doi request reprint Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Ann Intern Med 158:861-8. 2013
    ....
  8. doi request reprint Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K ant
    Jonathan P Piccini
    Division of Cardiology, Duke University Medical Center, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27710, USA
    Circulation 127:224-32. 2013
    ..We sought to define the factors associated with the occurrence of stroke and systemic embolism in a large, international atrial fibrillation (AF) trial...
  9. pmc Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stro
    Matthew W Sherwood
    Division of Cardiovascular Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC M W S, M R P, J P P, A S H, Y L, R M C, R C B Department of Medicine, Division of Hematology and Thromboembolism, McMaster University, Hamilton, Ontario, Canada J D D Department of Medicine, Division of Hematology, Hofstra North Shore LIJ School of Medicine, Lenox Hill Hospital, New York, NY A C S School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia G J H Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA D E S Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ C C N Department of Medicine, Stanford University Medical Center, Palo Alto, CA K W M and Department of Medicine, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom K A A F
    Circulation 129:1850-9. 2014
    ..We sought to determine reasons for TI, the characteristics of patients undergoing TI, and the relationship between anticoagulant and outcomes among patients with TI...
  10. doi request reprint High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 165:809-15, 815.e1. 2013
    ..We sought to characterize clinical outcomes and factors associated with outcomes after LE amputation in patients with PAD...
  11. doi request reprint Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial
    Jonathan P Piccini
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Am Coll Cardiol 61:1998-2006. 2013
    ..This study sought to investigate the outcomes following cardioversion or catheter ablation in patients with atrial fibrillation (AF) treated with warfarin or rivaroxaban...
  12. doi request reprint Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention o
    Manesh R Patel
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    J Am Coll Cardiol 61:651-8. 2013
    ..The purpose of this study was to understand the possible risk of discontinuation in the context of clinical care...
  13. doi request reprint Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
    Manesh R Patel
    Duke Cardiovascular Magnetic Resonance Center, Durham, NC, USA
    Am Heart J 165:226-33. 2013
    ..We examined the association among AbMI, other metrics of infarct size, and left ventricular (LV) function defined by cardiac magnetic resonance (CMR)...
  14. doi request reprint Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial
    Ka Sing Lawrence Wong
    From the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China K S L W Heart Center, Peking University People s Hospital, Beijing, China D Y H Department of Cardiology, Apollo Hospital, Chennai, India A O National Heart Centre, Singapore, Singapore R S T Department of Medicine, Division of Cardiology, Duke Clinical Research Institute M R P, K W M, R C B and Department of Medicine, Division of Cardiology, Duke Translational Medicine Institute R C, Duke University Medical Center, Durham, NC Department of Epidemiology, Massachusetts General Hospital and Harvard Medical School, Boston D E S Department of Cardiovascular Medicine, University Hospital Munster, Munster, Germany G B Centre for Cardiovascular Science, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, Scotland K A A F Bayer HealthCare Pharmaceuticals, Montville, NJ S D B Department of Neurology, Ruprecht Karls University, Heidelberg, Germany W H and Stroke Unit, Department of Neurology, Royal Perth Hospital, University of Western Australia, Perth, Australia G J H
    Stroke 45:1739-47. 2014
    ....
  15. doi request reprint Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008
    Manesh R Patel
    Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    JACC Cardiovasc Interv 5:1054-61. 2012
    ..This study sought to investigate the long-term effectiveness of drug-eluting stents (DES) versus bare-metal stents (BMS)...
  16. pmc Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction
    Sumeet Subherwal
    Duke University Medical Center, Durham, NC, USA
    Circ Cardiovasc Qual Outcomes 5:541-9. 2012
    ..The impact of polyvascular disease (peripheral arterial disease [PAD] and cerebrovascular disease [CVD]) on long-term cardiovascular outcomes among older patients with acute myocardial infarction has not been well studied...
  17. pmc Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes
    Adriano A M Truffa
    Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Durham, NC 27705, USA
    JACC Cardiovasc Interv 5:769-76. 2012
    ..We also assessed the association between serious infections and 90-day death or death/myocardial infarction (MI)...
  18. doi request reprint Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography
    Pamela S Douglas
    Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina, USA
    J Am Coll Cardiol 58:801-9. 2011
    ..The purpose of this study was to describe hospital variability in the rate of finding obstructive coronary artery disease (CAD) at elective coronary angiography...
  19. doi request reprint Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism
    Jonathan L Halperin
    From Icahn School of Medicine at Mount Sinai, New York, NY J L H School of Medicine and Pharmacology, University of Western Australia School of Medicine and Pharmacology, Perth, Australia G J H Duke Clinical Research Institute, Duke University Medical Center, Durham, NC D M W, J P P, Y L, M R P University of Münster, Munster, Germany G B Massachusetts General Hospital and Harvard Medical School, Boston, MA D E S University of Cincinnati College of Medicine, Cincinnati, OH R C B Ruprecht Karls University, Heidelberg, Germany W H Cerenis Therapeutics, Labege, France J F P Janssen Research and Development, Raritan, NJ C C N Stanford University School of Medicine, Stanford, CA K W M Duke Translational Medicine Institute, Duke University Medical Center, Durham, NC R M C and University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom K A A F
    Circulation 130:138-46. 2014
    ..This prespecified secondary analysis compares outcomes in older and younger patients...
  20. doi request reprint Percutaneous coronary interventions and cardiovascular outcomes for patients with chronic total occlusions
    E Marc Jolicœur
    Duke University Medical Center, Durham, North Carolina, USA
    Catheter Cardiovasc Interv 79:603-12. 2012
    ....
  21. doi request reprint Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial
    Manesh R Patel
    Division of Cardiology, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
    JAMA 306:1329-37. 2011
    ..Intra-aortic balloon counterpulsation (IABC) is an adjunct to revascularization in patients with cardiogenic shock and reduces infarct size when placed prior to reperfusion in animal models...
  22. doi request reprint Diagnosing acute myocardial infarction in patients with left bundle branch block
    Renato D Lopes
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 108:782-8. 2011
    ....
  23. doi request reprint Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
    Jeffrey B Washam
    Duke Heart Center, Duke University Medical Center, Durham, NC, USA
    Lancet 385:2363-70. 2015
    ..We studied the use and outcomes of digoxin in patients in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)...
  24. doi request reprint Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study
    Sumeet Subherwal
    Duke University Medical Center, Durham, NC, USA
    Eur J Prev Cardiol 22:317-25. 2015
    ..We aimed to examine whether PAD confers similar risk for mortality as incident myocardial infarction (MI) and whether risk differs by gender...
  25. doi request reprint Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
    Jonathan P Piccini
    Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27710, USA
    Eur Heart J 35:1873-80. 2014
    ..There are no data regarding management and outcomes of major bleeding events in patients treated with oral factor Xa inhibitors...
  26. pmc Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial
    Jonathan P Piccini
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    J Am Heart Assoc 3:e000521. 2014
    ..We assessed the relative effects of rivaroxaban versus warfarin at the level of trial center TTR (cTTR) since such analysis preserves randomized comparisons...
  27. pmc Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    J Am Coll Cardiol 60:2230-6. 2012
    ..This study sought to characterize temporal trends, patient-specific factors, and geographic variation associated with amputation in patients with lower-extremity peripheral artery disease (LE PAD) during the study period...
  28. pmc Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States
    Daniel W Mudrick
    Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 163:454-61. 2012
    ..Downstream procedures and subsequent outcomes among symptomatic patients without known coronary disease referred for stress testing are not well characterized in contemporary community practice...
  29. doi request reprint Promise of factor Xa inhibition in atrial fibrillation
    Sana M Al-Khatib
    Division of Cardiology, Department of Medicine, Duke Clinical Research Institute and Duke University, 2400 Pratt Street, PO Box 17969, Durham, NC 27705, USA
    Curr Cardiol Rep 14:70-8. 2012
    ....
  30. doi request reprint Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    Manesh R Patel
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    N Engl J Med 365:883-91. 2011
    ..Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin...
  31. doi request reprint Association between physician billing and cardiac stress testing patterns following coronary revascularization
    Bimal R Shah
    Duke Clinical Research Institute and Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina 27705, USA
    JAMA 306:1993-2000. 2011
    ..The degree to which financial factors may influence use of cardiac stress imaging procedures is unknown...
  32. pmc Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial
    Benjamin A Steinberg
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina Electronic address
    Heart Rhythm 11:925-32. 2014
    ..Antiarrhythmic drugs (AADs) and anticoagulation are mainstays of atrial fibrillation (AF) treatment...
  33. doi request reprint Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in North Carolina
    John P Vavalle
    Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina Electronic address
    Am J Cardiol 113:1874-8. 2014
    ..This suggests geographic treatment disparities as a result of access to surgical care that must be considered as new therapies for AS, such as transcatheter aortic valve replacement, are deployed...
  34. doi request reprint Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF
    William Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Box 3126, Durham, NC, USA
    Eur Heart J 35:242-9. 2014
    ....
  35. doi request reprint Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial)
    Sreekanth Vemulapalli
    Division of Cardiology, Duke University Medical Center, Durham, North Carolina Electronic address
    Am J Cardiol 112:911-7. 2013
    ..These findings underscore the importance of systems of care aimed at reducing total ischemic time to open infarct arteries...
  36. doi request reprint The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale
    Chiara Melloni
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 164:646-653.e3. 2012
    ..Information gained from the SOLSTICE trial will inform further testing of this agent in larger clinical trials...
  37. pmc Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry
    Sumeet Subherwal
    Duke University, Durham, NC, USA
    J Am Coll Cardiol 62:51-7. 2013
    ..The aim of this paper was to examine disparities in the use of cardioprotective medications in the treatment of peripheral artery disease (PAD) by socioeconomic status (SES)...
  38. doi request reprint Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains
    Sumeet Subherwal
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Circulation 126:1345-54. 2012
    ....
  39. doi request reprint Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008
    J Matthew Brennan
    Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 59:648-54. 2012
    ..This study sought to assess percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) stenosis in routine U.S. clinical practice...
  40. doi request reprint Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006
    Manesh R Patel
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
    Arch Intern Med 170:1218-25. 2010
    ..We examined geographic variation in and predictors of carotid endarterectomy and carotid stenting...
  41. doi request reprint Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis
    Sreekanth Vemulapalli
    Division of Cardiology, Duke University Medical Center, Durham, NC Electronic address
    Am Heart J 169:924-937.e3. 2015
    ..Unsupervised exercise (UE) represents a less costly alternative. We assessed the comparative effectiveness of SE vs UE in patients with IC...
  42. doi request reprint Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC Division of Cardiology, Duke University Medical Center, Durham, NC Electronic address
    Am Heart J 167:489-498.e7. 2014
    ..We performed a systematic review and meta-analysis to assess the comparative effectiveness of endovascular revascularization and surgical revascularization in patients with CLI...
  43. doi request reprint A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department
    Zainab Samad
    Division of Cardiovascular Medicine, Duke University Medical Center DUMC, Durham, NC 27710, USA
    J Nucl Cardiol 19:364-76. 2012
    ....
  44. doi request reprint Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States
    Prashant Kaul
    Duke University Medical Center, Durham, NC, USA
    Circulation 122:2160-9. 2010
    ..Invasive and noninvasive cardiovascular imaging is beneficial in the care of patients admitted with acute myocardial infarction. Little is known about patients' cumulative radiation exposure...
  45. doi request reprint ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of T
    Manesh R Patel
    Duke University Medical Center, Durham, NC, USA
    Circulation 119:1330-52. 2009
    ..It is anticipated that these results will have an impact on physician decision making and patient education regarding expected benefits from revascularization and will help guide future research...
  46. doi request reprint International variation in and factors associated with hospital readmission after myocardial infarction
    Robb D Kociol
    Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27715, USA
    JAMA 307:66-74. 2012
    ..Recently, 30-day readmission rates have been proposed as a metric for care of patients with STEMI. However, international rates and predictors of 30-day readmission after STEMI have not been studied...
  47. doi request reprint Quality of care for atrial fibrillation among patients hospitalized for heart failure
    Jonathan P Piccini
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 54:1280-9. 2009
    ..This study sought to examine quality of care and warfarin use at discharge in patients with atrial fibrillation (AF) and heart failure (HF)...
  48. ncbi request reprint Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)
    Manesh R Patel
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 95:614-8. 2005
    ..Baseline and serial measurements of WBC counts and temperature were correlated with infarct size and clinical outcome...
  49. ncbi request reprint Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation
    Manesh R Patel
    Duke University Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Drugs Aging 19:633-46. 2002
    ..An evidence-based approach to the treatment of elderly patients with ACS without persistent ST segment elevation will help to improve the use of beneficial therapies and interventions that are recommended by current practice guidelines...
  50. doi request reprint Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina Department of Medicine, Duke University School of Medicine, Durham, North Carolina Electronic address
    J Am Coll Cardiol 65:920-7. 2015
    ..In 2008, Medicare modified reimbursement rates to encourage more efficient outpatient use of PVI in the United States...
  51. doi request reprint Proceedings from Duke resistant hypertension think tank
    Sreekanth Vemulapalli
    Division of Cardiology, Duke University Medical Center, Durham, NC
    Am Heart J 167:775-88.e1. 2014
    ....
  52. doi request reprint Association of the ankle-brachial index with history of myocardial infarction and stroke
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC Electronic address
    Am Heart J 167:499-505. 2014
    ..The association of ABI levels and myocardial infarction (MI) and stroke is less certain. We sought to further characterize the association between ABI levels and history of MI and stroke...
  53. doi request reprint Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina
    W Schuyler Jones
    Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 162:932-7. 2011
    ..We evaluated the temporal trends and variation in invasive Cath, PCI, and CABG across hospital systems in North Carolina...
  54. pmc Low diagnostic yield of elective coronary angiography
    Manesh R Patel
    Duke Clinical Research Institute, Duke University, Durham, NC 27715, USA
    N Engl J Med 362:886-95. 2010
    ..We determined patterns of noninvasive testing and the diagnostic yield of catheterization among patients with suspected coronary artery disease in a contemporary national sample...
  55. doi request reprint Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial
    Manesh R Patel
    Duke University, Durham, North Carolina 27710, USA
    JACC Cardiovasc Imaging 3:52-60. 2010
    ..The purpose of the study was to understand determinants of infarct size in a primary percutaneous intervention (PCI) population treated with pexelizumab compared with placebo...
  56. ncbi request reprint A comparison of acute coronary syndrome care at academic and nonacademic hospitals
    Manesh R Patel
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am J Med 120:40-6. 2007
    ..We sought to identify hospital characteristics associated with high levels of adherence in order to gain insight into successful processes of care...
  57. ncbi request reprint Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: the 30-day outcome associated with normal left ventricular wall motion
    Patrick Weston
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 148:1096-101. 2004
    ....
  58. doi request reprint Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    E Marc Jolicoeur
    Duke Clinical Research Institute, Box 3409, Durham, NC 27710, USA
    Eur Heart J 30:2575-83. 2009
    ..We describe the association between transfusion and 90-day mortality among patients with acute myocardial infarction treated with primary percutaneous coronary intervention...
  59. doi request reprint Patterns of cardiac stress testing after revascularization in community practice
    Bimal R Shah
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    J Am Coll Cardiol 56:1328-34. 2010
    ..The purpose of this study was to determine the pattern of cardiac stress testing after coronary revascularization in community practice...
  60. doi request reprint Geographic variation and trends in carotid imaging among medicare beneficiaries, 2001 to 2006
    Lesley H Curtis
    Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Circ Cardiovasc Qual Outcomes 3:599-606. 2010
    ..We examined temporal trends and geographic variation in the use of carotid ultrasound, carotid magnetic resonance angiography (MRA), and carotid x-ray angiography...
  61. ncbi request reprint Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes
    Trip J Meine
    Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 95:976-8. 2005
    ..Propensity analysis was used to match patients. Transdermal nicotine therapy appears safe and does not have an effect on the mortality of patients with acute coronary syndromes...
  62. doi request reprint Amplatzer vascular plug closure of a subclavian arteriovenous fistula associated with implantable cardioverter-defibrillator implantation
    Connie Ng Hess
    Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
    Catheter Cardiovasc Interv 77:761-3. 2011
    ..The Amplatzer vascular plug should be considered as a potential treatment strategy for AVFs alongside other endovascular and surgical techniques...
  63. doi request reprint A case of mistaken identity: persistent sciatic artery stenosis as a cause of critical limb ischemia
    W Schuyler Jones
    Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Catheter Cardiovasc Interv 77:308-12. 2011
    ..As more endovascular procedures are being done by cardiologists, knowledge of aberrant anatomy is essential in the approach to diagnosis and treatment of patients with PAD. © 2011 Wiley-Liss, Inc...
  64. ncbi request reprint Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction
    Manesh R Patel
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 151:316-22. 2006
    ..Cardiac tamponade is a life-threatening complication of acute myocardial infarction (MI). Data on the incidence, risk factors, and outcome of tamponade in patients with acute MI in the fibrinolytic era are limited...
  65. ncbi request reprint Highlights from the American College of Cardiology Annual Scientific Sessions 2004: March 9-12, 2004
    Svati H Shah
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 148:254. 2004
  66. ncbi request reprint Cardiac imaging impaired by a silicone breast implant
    Trip J Meine
    Duke Clinical Research Institute, Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27715, USA
    Clin Nucl Med 30:262-4. 2005
    ..This case of a left-sided silicone breast implant interfering with nuclear imaging of the myocardium highlights the importance of understanding the potential interference from silicone breast implants...
  67. ncbi request reprint Pexelizumab: a novel therapy for myocardial ischemia-reperfusion
    Manesh R Patel
    Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Drugs Today (Barc) 41:165-70. 2005
    ....
  68. ncbi request reprint Highlights from the American College of Cardiology Annual Scientific Session 2005: March 6 to 9, 2005, Orlando, Florida
    Manesh R Patel
    Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Am Heart J 149:1009-19. 2005
  69. ncbi request reprint The role of cardiovascular MRI in heart failure and the cardiomyopathies
    James A White
    Department of Medicine, Division of Cardiology, University of Western Ontario, 1151 Richmond Street, Suite 2, London, Ontario, Canada N6A 5B8
    Cardiol Clin 25:71-95, vi. 2007
    ..This article outlines a diagnostic approach for the primary use of CMR in the phenotypic characterization, risk stratification, and therapeutic management of patients with HF...
  70. ncbi request reprint Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction
    Trip J Meine
    Duke University Medical Center, Durham, North Carolina, USA
    Ann Intern Med 143:481-5. 2005
    ....
  71. ncbi request reprint Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging
    Pamela Douglas
    Duke University Medical Center 3943, Duke North 7451, Durham, North Carolina 27710, USA
    J Am Coll Cardiol 48:2141-51. 2006
    ....
  72. pmc Randomized trial for answers to clinical questions: evaluating a pre-appraised versus a MEDLINE search protocol
    Manesh R Patel
    Duke University Medical Center, Durham, North Carolina, USA
    J Med Libr Assoc 94:382-7. 2006
    ..The paper compares the speed, validity, and applicability of two different protocols for searching the primary medical literature...
  73. ncbi request reprint The case of the disappearing myxoma
    John F Heitner
    Division of Cardiology, New York Methodist Hospital, Brooklyn, NY 11215, USA
    J Cardiovasc Magn Reson 7:841-3. 2005
    ..Thus, unwarranted and potentially risky thoracic surgery was avoided by the incorporation of a systematic evaluation by cardiac MRI...
  74. ncbi request reprint Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early
    Manesh R Patel
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 152:641-7. 2006
    ..We sought to determine the prevalence, predictors, and outcomes of patients with NSTEMI and insignificant CAD...
  75. ncbi request reprint Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents
    Manesh R Patel
    Cardiovascular Magnetic Resonance Center and Clinical Research Institute, Duke University Medical Center, 2400 Pratt St, Durham, NC 27705, USA
    Radiology 240:674-80. 2006
    ..To retrospectively determine the safety of cardiac magnetic resonance (MR) imaging performed early (<14 days) after coronary stent implantation in patients with acute myocardial infarction (AMI)...
  76. ncbi request reprint Relation of ventricular premature complexes during recovery from a myocardial perfusion exercise stress test to myocardial ischemia
    Trip J Meine
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 97:1570-2. 2006
    ..27, 95% confidence interval 1.04 to 1.56, p = 0.017), whereas VPCs during stress were not (p = 0.128). In conclusion, VPCs during the recovery phase of an exercise study are predictive of ischemia on myocardial perfusion imaging...
  77. ncbi request reprint State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction
    Manesh R Patel
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 44:192-8. 2004
    ..The purpose of this study was to determine whether state-mandated continuing medical education (CME) requirements affect the use of evidence-based therapies and outcomes in patients with acute myocardial infarction (AMI)...
  78. ncbi request reprint To transfer or not to transfer: acute myocardial infarction reperfusion
    Manesh R Patel
    Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 147:573-4. 2004
  79. doi request reprint Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study)
    Manesh R Patel
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 103:181-6. 2009
    ..In conclusion, in this observational analysis of stent use from a large primary percutaneous intervention for acute MI trial, DESs appear as safe as BMSs with similar 6-month clinical outcomes with regard to death and recurrent MI...
  80. ncbi request reprint An intracardiac mass in a young man with congenitally acquired HIV
    Manesh R Patel
    Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
    Cardiol Rev 12:126-30. 2004
    ..A case of a 19-year-old man with congenitally acquired HIV infection who was found to have a large intracardiac mass is presented. Presurgical imaging studies and subsequent pathologic findings and histology are discussed...
  81. ncbi request reprint The value of looking. Multiple myeloma discovered by an unusual finding in Gram-stained spinal fluid
    Manesh R Patel
    Department of Medicine, Duke University Medical Center, Box 31152, Durham, NC 27710, USA
    N C Med J 63:129-30. 2002
  82. ncbi request reprint Provisional stenting versus routine stenting: is it worth the price?
    Manesh R Patel
    Duke Clinical Research Institute, Durham, NC 27705, USA
    J Invasive Cardiol 15:634-5. 2003
  83. ncbi request reprint Access site for cardiac catheterization
    Manesh R Patel
    Division of Cardiology and the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 147:1-2. 2004
  84. doi request reprint Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC Department of Medicine, Duke University Medical Center, Durham, NC Electronic address
    Am Heart J 170:400-8. 2015
    ..We empirically created an anatomic runoff score (ARS) to approximate the burden of LE PAD and determined its association with clinical outcomes...
  85. pmc EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy
    Thomas J Povsic
    Duke Clinical Research Institute, Duke University Medical Center, Box 103208, Durham, NC, 27710, USA
    J Thromb Thrombolysis 36:375-83. 2013
    ..High-dose (≥30,000 U) EPO may mobilize EPCs at 48-72 h, and baseline EPC levels may be inversely associated with infarct size...
  86. doi request reprint Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome
    W Schuyler Jones
    Department of Medicine, Duke University Medical Center, Durham, North Carolina
    Clin Cardiol 37:152-9. 2014
    ..Although atrial fibrillation (AF) occurs frequently in patients hospitalized with acute coronary syndrome (ACS), strategies for prevention of thromboembolic complications are poorly characterized...
  87. pmc Cardiovascular complications of breast cancer therapy in older adults
    Chetan Shenoy
    Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Oncologist 16:1138-43. 2011
    ..In this review, we discuss the risk factors and strategies for prevention and management of cardiovascular complications in older women with breast cancer...
  88. doi request reprint A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces I
    Manesh R Patel
    Duke Clinical Research Institute, Duke University, Durham, NC 27705, USA
    Am Heart J 162:47-55.e1. 2011
    ..Intraaortic balloon counterpulsation (IABC) is an adjunct to revascularization and has reduced microvascular obstruction and infarct size in animal models of AMI...
  89. doi request reprint Achieving Quality in Cardiovascular Imaging II: proceedings from the Second American College of Cardiology -- Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging
    Pamela S Douglas
    Division of Cardiovascular Medicine, Duke University Medical Center, Durham, NC 27715, USA
    JACC Cardiovasc Imaging 2:231-40. 2009
    ..The second American College of Cardiology-Duke University Think Tank continued the process of the development, dissemination, and adoption of quality improvement initiatives for all cardiovascular imaging modalities...
  90. pmc Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial
    Chiara Melloni
    Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 160:795-803.e2. 2010
    ..Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin may reduce infarct size, decrease apoptosis, and increase neovascularization, possibly through mobilization of endothelial progenitor cells...
  91. doi request reprint Cardiovascular events in patients with fabry disease natural history data from the fabry registry
    Manesh R Patel
    Division of Cardiovascular Medicine, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Am Coll Cardiol 57:1093-9. 2011
    ..These analyses were designed to determine the incidence of major cardiovascular (CV) events and the natural history of CV complications in patients with Fabry disease...
  92. doi request reprint Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk
    Rajendra H Mehta
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 161:782-9. 2011
    ....
  93. pmc Detection of myocardial damage in patients with sarcoidosis
    Manesh R Patel
    Duke Cardiovascular Magnetic Resonance Center, Duke University Medical Center, Durham, NC 27710, USA
    Circulation 120:1969-77. 2009
    ..Delayed-enhancement cardiovascular magnetic resonance (DE-CMR) can detect minute amounts of myocardial damage. We sought to compare DE-CMR with standard clinical evaluation for the identification of cardiac involvement...
  94. ncbi request reprint Peripheral arterial disease: an overview of endovascular therapies and contemporary treatment strategies
    Kanwar P Singh
    Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
    Rev Cardiovasc Med 7:55-68. 2006
    ..The current standard of care for significant carotid artery stenosis can include carotid stenting and carotid endarterectomy, but medical therapy may have a role also...
  95. ncbi request reprint Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative
    Trip J Meine
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 149:1043-9. 2005
    ..The CRUSADE Initiative is a nonrandomized, retrospective, observational registry enrolling patients with NSTE ACS to evaluate acute medications and interventions, inhospital outcomes, and discharge treatments...
  96. doi request reprint Appropriateness of percutaneous coronary intervention: a review
    Matthew R Summers
    Division of Cardiovascular Diseases, Duke University Medical Center, Durham, NC 27710, USA
    Curr Cardiol Rep 15:379. 2013
    ..Important data published in 2012 that further evaluates the role of percutaneous coronary intervention will also be reviewed with a focus on its potential impact on future iterations of the appropriateness criteria. ..
  97. doi request reprint Interventional treatment of hypertension: a new paradigm
    W Schuyler Jones
    Duke Clinical Research Institute, Duke University Medical Center, Box 3126, Durham, NC, 27710, USA
    Curr Cardiol Rep 15:356. 2013
    ..The results of prior studies and new studies of interventional treatments of resistant hypertension are covered in this review...
  98. doi request reprint ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization : a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of
    Manesh R Patel
    Division of Cardiology, Duke University Medical Center, Durham, NC, USA
    Catheter Cardiovasc Interv 73:E1-24. 2009
    ..It is anticipated that these results will have an impact on physician decision making and patient education regarding expected benefits from revascularization and will help guide future research...
  99. pmc Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION)
    W Schuyler Jones
    Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 108:380-4. 2011
    ..62, p = 0.011). Patients with PAD and HF had deceased baseline exercise capacity and decreased response to exercise training. In conclusion, PAD is an independent predictor of all-cause death or hospitalization in patients with HF...
  100. doi request reprint Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Contemp Clin Trials 29:887-95. 2008
    ..The operational paradigm of this effort should be considered in future investigations so that important advances in clinical care of disease can be realized efficiently...
  101. doi request reprint ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emerg
    Pamela S Douglas
    Duke University Medical Center, Durham, NC, USA
    Circulation 117:1478-97. 2008
    ..It is anticipated that these results will have a significant impact on physician decision making and performance, reimbursement policy, and will help guide future research...